Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study

被引:0
|
作者
Cem Onal
Ozan Cem Guler
Pervin Hurmuz
Guler Yavas
Burak Tilki
Ezgi Oymak
Cagdas Yavas
Gokhan Ozyigit
机构
[1] Adana Dr. Turgut Noyan Research and Treatment Center,Department of Radiation Oncology
[2] Baskent University Faculty of Medicine,Department of Radiation Oncology
[3] Hacettepe University Faculty of Medicine,Department of Radiation Oncology
[4] Baskent University Faculty of Medicine,Division of Radiation Oncology
[5] Iskenderun Gelisim Hospital,undefined
来源
Strahlentherapie und Onkologie | 2022年 / 198卷
关键词
Renal cell carcinoma; Bone metastasis; Oligometastasis; Stereotactic body radiotherapy; Radiotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:940 / 948
页数:8
相关论文
共 50 条
  • [1] Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study
    Onal, Cem
    Guler, Ozan Cem
    Hurmuz, Pervin
    Yavas, Guler
    Tilki, Burak
    Oymak, Ezgi
    Yavas, Cagdas
    Ozyigit, Gokhan
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (10) : 940 - 948
  • [2] Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study
    Onal, Cem
    Oymak, Ezgi
    Guler, Ozan Cem
    Tilki, Burak
    Yavas, Guler
    Hurmuz, Pervin
    Yavas, Cagdas
    Ozyigit, Gokhan
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (05) : 456 - 464
  • [3] Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study
    Cem Onal
    Ezgi Oymak
    Ozan Cem Guler
    Burak Tilki
    Guler Yavas
    Pervin Hurmuz
    Cagdas Yavas
    Gokhan Ozyigit
    Strahlentherapie und Onkologie, 2023, 199 : 456 - 464
  • [4] Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma
    Guler, Ozan Cem
    Oymak, Ezgi
    Hurmuz, Pervin
    Yavas, Guler
    Tilki, Burak
    Yavas, Cagdas
    Ozyigit, Gokhan
    Onal, Cem
    UROLOGIA INTERNATIONALIS, 2023, 107 (02) : 171 - 178
  • [5] Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis
    Nicosia, Luca
    Franzese, Ciro
    Mazzola, Rosario
    Franceschini, Davide
    Rigo, Michele
    D'agostino, Giuseppe
    Corradini, Stefanie
    Alongi, Filippo
    Scorsetti, Marta
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (03) : 213 - 221
  • [6] The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma
    Onal, Cem
    Hurmuz, Pervin
    Guler, Ozan Cem
    Yavas, Guler
    Tilki, Burak
    Oymak, Ezgi
    Yavas, Cagdas
    Ozyigit, Gokhan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (08): : 1533 - 1541
  • [7] The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma
    Cem Onal
    Pervin Hurmuz
    Ozan Cem Guler
    Guler Yavas
    Burak Tilki
    Ezgi Oymak
    Cagdas Yavas
    Gokhan Ozyigit
    Clinical and Translational Oncology, 2022, 24 : 1533 - 1541
  • [8] Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma
    Ranck, Mark C.
    Golden, Daniel W.
    Corbin, Kimberly S.
    Hasselle, Michael D.
    Liauw, Stanley L.
    Stadler, Walter M.
    Hahn, Olwen M.
    Weichselbaum, Ralph R.
    Salama, Joseph Kamel
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (06): : 589 - 595
  • [9] Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 20-04)
    Kim, Tae Hyung
    Nam, Taek-Keun
    Yoon, Sang Min
    Kim, Tae Hyun
    Choi, Young Min
    Seong, Jinsil
    CANCERS, 2022, 14 (23)
  • [10] Stereotactic Ablative Radiotherapy for Bone-Only Oligometastatic Breast Cancer: On a Quest to Find the Optimum Cohort
    Yilmaz, M. T.
    Gultekin, M.
    Sari, S. Yuce
    Kumru, T.
    Kivanc, H.
    Ozyigit, G.
    Yildiz, F.
    CLINICAL ONCOLOGY, 2025, 37